Needham analyst Mike Matson reiterated a Hold rating on ICU Medical (NASDAQ: ICUI).The analyst commented: "ICUI's 4Q24 revenue, EBITDA, and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE